Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.

Saved in:
Bibliographic Details
Title: Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment.
Authors: Emara HM; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu., Youness RA; Molecular Biology and Biochemistry Department, Molecular Genetics Research Team, Faculty of Biotechnology, German International University (GIU) New Administrative Capital 11835 Egypt., Manie TM; Breast Surgery Department, National Cancer Institute, Faculty of Medicine, Cairo University Cairo Egypt., Abdelnaser A; Institute of Global Health and Human Ecology, School of Sciences and Engineering, AUC - American University in Cairo New Cairo Egypt anwar.abdelnaser@aucegypt.edu., Allam NK; Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt Nageh.allam@aucegypt.edu.; Energy Materials Laboratory, Physics Department, School of Sciences & Engineering, The American University in Cairo New Cairo 11835 Egypt.
Source: Nanoscale advances [Nanoscale Adv] 2026 Feb 19; Vol. 8 (7), pp. 2333-2350. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101738708 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-0230 (Electronic) Linking ISSN: 25160230 NLM ISO Abbreviation: Nanoscale Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2516-0230
DOI:10.1039/d5na01082a